Authors

• Nancy S. Redeker (ORCID: https://orcid.org/0000-0001-7817-2708)
• Kelly S. DeMartini (ORCID: https://orcid.org/0000-0003-0943-2507)
• Stephanie S. O’Malley (ORCID: https://orcid.org/0000-0002-1976-2369)
• Nancy P. Barnett (ORCID: https://orcid.org/0000-0001-9634-8287)
• Garrett I. Ash (ORCID: https://orcid.org/0000-0002-8655-7525)
• Lisa M. Fucito (ORCID: https://orcid.org/0000-0001-9410-2830)
• Chiang-Shan Ray Li (ORCID: https://orcid.org/0000-0002-9393-1212)
• Brian Pittman (ORCID: https://orcid.org/0000-0002-0353-5604)
• Ruiyang Wu (ORCID: https://orcid.org/0000-0003-2331-817X)

Institutions

• University of Connecticut (US)
• Brown University (US)
• Yale Cancer Center (US)
• Yale University (US)
• VA Connecticut Healthcare System (US)

Publication Details

Journal

JAMA Network Open

Published

2025-05-30

DOI

https://doi.org/10.1001/jamanetworkopen.2025.13167

Citations

6

Primary Topic

Substance Abuse Treatment and Outcomes

Type

article

Field-Weighted Citation Impact

8.13

Funders

• Eli Lilly and Company
• Novartis
• Yale University
• Indivior
• National Institutes of Health